The Palla Pharma Ltd (ASX: PAL) share price is up 30% today after the company announced a change in its manufacturing facility.
The post Palla Pharma (ASX:PAL) share price rockets 30% higher. Here’s why appeared first on The Motley Fool Australia. –
The Palla Pharma Ltd (ASX: PAL) share price is among the top performers on the ASX market today. This comes after the company announced that it had received approval to change its manufacturing site to its Norway production facility.
During late afternoon trade, shares in the opiate-based pain relief medicine company are up 30.3% to 73 cents. It’s worth noting that the company’s shares rose to an intraday high of 82 cents in the first hour of market open.
Production facility change
The Palla Pharma share price is on the move after reporting a significant tailwind in its operations.
In today’s release, Palla Pharma advised that United Kingdom’s medicines regulator, MHRA, has given the green light to change the manufacturing site for its Co-Codamol tablet.
Palla Pharma’s Co-Codamol products contain two painkilling ingredients, paracetamol and codeine. The tablet form product relieves short-lasting painful conditions where paracetamol alone is insufficient.
In addition to the approval, the regulator also gave the nod for the company’s required marketing authorisations, as well as patient information leaflets and product packaging.
As a result, Palla Pharma immediately began producing its initial batches of the product in bulk. Once it has completed the packing process, it will move onto its sales process. The company noted that production would ramp up to meet the anticipated demand for the coming months.
The UK is the biggest market in Europe for painkiller relief tablets. Each kilogram of codeine phosphate sold as part of the approved Co-Codamol product has a higher gross margin than in active pharmaceutical ingredient form or tableted form as a contract manufacturer. This in-turn represents an increase in revenue generation for the company.
Palla Pharma revealed that it would release its full-year results on Friday, 26 February.
About the Palla Pharma share price
The Palla Pharma share price has taken investors on a rollercoaster ride in the past 12 months. The company’s shares dipped to an all-time low of 45 cents in March, before storming to a 52-week high of $1.08.
At today’s current share price of 72 cents, Palla Pharma is down around 15% from this time last year.
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of February 15th 2021
- Abacus Property (ASX:ABP) just revealed 85% profit growth in HY21
- Top brokers name 3 ASX shares to sell today
- What’s going on with the MyFiziq (ASX:MYQ) share price today?
- Here’s why the Mach7 (ASX:M7T) share price is down 6% today
- Why the EML Payments (ASX:EML) share price is still pushing higher
Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.